Certain blood tests have been recalled due to risk for false negative or falsely low cardiac troponin levels. The FDA designated the recall as serious due to the risks of a missed or delayed MI ...
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs ...
A single troponin level measurement test and an electrocardiogram may be sufficient to rule out the risk of a heart attack in patients complaining of chest pain, according to a study in the Journal of ...
Using age-specific thresholds for troponin measurement would more accurately diagnose myocardial injury when assessing patients for suspected myocardial infarction (MI), a new study suggests. The ...
The committee heard from a patient expert who highlighted the stresses and fears that patients and their families experience when attending the emergency department with chest pain. Reducing waiting ...
High-sensitivity cardiac troponin testing can identify patients with stable coronary artery disease who have a greater risk for MI or cardiovascular death, a study conducted in Scotland indicates.
BEDFORD PARK, AUSTRALIA — Use of high-sensitivity troponin T (hs-TnT) assays, compared with standard TnT assays, may result in only modest improvement in evaluating emergency-department patients with ...
Background and Goal: Chest pain is a common but challenging symptom for general practitioners to evaluate, as it can be caused by both serious conditions and more benign issues. This study assessed ...
TARRYTOWN, N.Y.--(BUSINESS WIRE)--A new prognosis claim for the Siemens Healthineers Atellica IM High-Sensitivity Troponin I (TnIH) test 1 immediately advances care for at-risk cardiac patients in the ...
A new test has been developed in Turku, Finland, that helps in separating heart attack patients from those whose cardiac troponin values are elevated due to renal insufficiency. Blood sample tests for ...
Chest pain and suspected myocardial infarction were the cause of about 5% of all emergency hospital admissions in 2017 to 2018. However, myocardial infarction will have occurred in only about 20% of ...
Brea-based Beckman Coulter Inc. is on schedule to have a profitable heart test back on the market by midyear, according to a regulatory filing by the maker of medical diagnostic products. Beckman said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback